Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?


OverviewForecastRevenueFinancialsChartTranscripts

Ocular Therapeutix Ownership Summary


Ocular Therapeutix is owned by 90.91% institutional investors, 3.37% insiders, and 5.72% retail investors. Blackrock is the largest institutional shareholder, holding 8.73% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.68% of its assets in Ocular Therapeutix shares.

OCUL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOcular Therapeutix90.91%3.37%5.72%
SectorHealthcare Stocks 479.67%11.03%-390.70%
IndustryBiotech Stocks 295.80%10.97%-206.77%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.52M8.73%$78.80M
Deep track capital, lp14.29M8.28%$132.65M
Summer road13.89M8.05%$128.88M
Vr adviser12.76M7.39%$118.44M
Blackrock funding, inc. /de10.55M6.11%$97.87M
Vanguard group8.48M5.08%$72.45M
Avoro capital advisors7.40M4.29%$68.67M
Tcg crossover management5.32M3.08%$49.36M
State street3.92M2.97%$26.82M
Opaleye management4.34M2.60%$37.08M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Summer road13.89M98.23%$128.88M
Acuta capital partners1.01M13.15%$9.42M
Vr adviser12.76M8.88%$118.44M
Opaleye management4.34M6.49%$37.08M
Tcg crossover management5.32M5.64%$49.36M
Rosalind advisors1.13M4.93%$9.64M
Deltec asset management2.79M4.62%$25.94M
Deep track capital, lp14.29M4.25%$132.65M
Octagon capital advisors lp2.42M3.41%$20.71M
Saturn v capital management728.58K2.74%$6.76M

Top Buyers

HolderShares% AssetsChange
Blackrock11.52M0.00%3.46M
State street3.92M0.00%1.52M
Bank of america corp /de/1.04M0.00%809.12K
Raymond james financial884.38K0.00%520.14K
Rosalind advisors1.13M4.93%243.70K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---2.24M
Great point partners---1.73M
Blackrock funding, inc. /de10.55M0.00%-1.47M
Adage capital partners gp3.89M0.06%-1.31M
Perceptive advisors---915.77K

New Positions

HolderShares% AssetsChangeValue
Imc-chicago207.76K0.00%207.76K$1.93M
Weiss asset management lp187.62K0.02%187.62K$1.74M
Dark forest capital management lp161.90K0.06%161.90K$1.50M
Courier capital56.44K0.03%56.44K$481.98K
Hudson bay capital management lp54.09K0.00%54.09K$501.95K

Sold Out

HolderChange
Financial gravity asset management-1.00
Parallel advisors-1.00
Nelson, van denburg & campbell wealth management group-17.00
Stephens consulting-50.00
Coldstream capital management-70.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025192-4.48%156,898,61016.16%901.43%963.23%47-20.34%
Mar 31, 20252028.60%137,366,9062.63%811.26%93-1.06%6057.89%
Dec 31, 20241772.31%128,615,765-8.11%771.10%8914.10%36-21.74%
Sep 30, 202417213.91%139,954,0592.07%830.78%79-13.19%4670.37%
Jun 30, 2024151-0.66%137,118,55510.64%1031.18%91-14.95%2717.39%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S7.46M4.68%5.14M
Fidelity Growth Company Fund6.01M3.77%4.38M
Vanguard US Total Market Shares ETF4.64M2.92%-
Vanguard Total Stock Mkt Idx Inv4.70M2.72%-104.94K
iShares Russell 2000 ETF3.32M1.92%-63.10K
Fidelity Small Cap Index1.60M1.01%1.16K
Fidelity Series Growth Company1.55M0.97%1.10M
Fidelity Growth Company K61.44M0.90%945.81K
Fidelity Select Pharmaceuticals Port1.31M0.82%346.20K
Vanguard Institutional Extnd Mkt Idx Tr1.38M0.80%-593.25K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 02, 2025Waheed Nadia Chief Medical OfficerSell$111.58K
May 23, 2025Nayak Sanjay Chief Strategy OfficerSell$13.35K
May 23, 2025Kaiser Peter Chief Development OfficerSell$21.32K
May 23, 2025Heier Jeffrey S. Chief Scientific OfficerSell$21.71K
May 23, 2025Dugel Pravin See RemarksSell$152.35K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q215
2025 Q1-6
2024 Q4-4
2024 Q3-2

OCUL Ownership FAQ


Who Owns Ocular Therapeutix?

Ocular Therapeutix shareholders are primarily institutional investors at 90.91%, followed by 3.37% insiders and 5.72% retail investors. The average institutional ownership in Ocular Therapeutix's industry, Biotech Stocks , is 295.80%, which Ocular Therapeutix falls below.

Who owns the most shares of Ocular Therapeutix?

Ocular Therapeutix’s largest shareholders are Blackrock (11.52M shares, 8.73%), Deep track capital, lp (14.29M shares, 8.28%), and Summer road (13.89M shares, 8.05%). Together, they hold 25.05% of Ocular Therapeutix’s total shares outstanding.

Does Blackrock own Ocular Therapeutix?

Yes, BlackRock owns 8.73% of Ocular Therapeutix, totaling 11.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 78.8M$. In the last quarter, BlackRock increased its holdings by 3.46M shares, a 42.87% change.

Who is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested?

Summer road is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested, with 98.23% of its assets in 13.89M Ocular Therapeutix shares, valued at 128.88M$.

Who is the top mutual fund holder of Ocular Therapeutix shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ocular Therapeutix shares, with 4.68% of its total shares outstanding invested in 7.46M Ocular Therapeutix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools